For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Ketamine lozenges in Tauranga for treatment-resistant depression or anxiety
+News
Ketamine lozenges in Tauranga for treatment-resistant depression or anxiety
Tuesday 30 June 2020, 03:16 PM

Psychiatrist Caleb Armstrong’s Tauranga clinic Anteris will offer ketamine lozenges for people with treatment-resistant depression or anxiety
“It seems it’s a much better roll of the dice than any of the treatments that can be offered in those cases”
A new clinic in Tauranga will offer
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
References
Andrade C. Oral Ketamine for Depression, 1: Pharmacologic Considerations and Clinical Evidence. J Clin Psychiatry 2019;80(2) 2 April
https://www.psychiatrist.com/JCP/article/Pages/2019/v80/19f12820.aspx